Greenwich LifeSciences, Inc. (GLSI) Corporate Subsidiaries
Greenwich LifeSciences, Inc. (GLSI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GLSI
CIK: 1799788
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJoe Longoria
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001493152-26-037147 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | 4 | 0001493152-26-035310 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001493152-26-035085 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 | 0001493152-26-034675 | View SEC Doc Filr Page |
| 10-Q | 2026-06-04 | 2026-03-31 | 10-Q | 0001493152-26-027150 | View SEC Doc Filr Page |
| 10-K | 2026-06-01 | 2025-12-31 | 10-K | 0001493152-26-026651 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001493152-26-014218 | View SEC Doc Filr Page |
| 4 | 2026-01-15 | 2026-01-13 | 4 | 0001493152-26-002319 | View SEC Doc Filr Page |
| 4 | 2026-01-14 | 2026-01-12 | 4 | 0001493152-26-002112 | View SEC Doc Filr Page |
| 4 | 2026-01-05 | 2025-12-31 | 4 | 0001493152-26-000229 | View SEC Doc Filr Page |
| 4 | 2026-01-02 | 2025-12-30 | 4 | 0001493152-26-000006 | View SEC Doc Filr Page |
| 4 | 2025-12-19 | 2025-12-18 | 4 | 0001493152-25-028424 | View SEC Doc Filr Page |
| 8-K | 2025-12-18 | 2025-12-18 | 8-K | 0001493152-25-028361 | View SEC Doc Filr Page |
| 4 | 2025-11-28 | 2025-11-25 | 4 | 0001493152-25-025282 | View SEC Doc Filr Page |
| 4 | 2025-11-17 | 2025-11-13 | 4 Filing | 0001493152-25-023719 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | 10-Q | 0001493152-25-023539 | View SEC Doc Filr Page |
| 4 | 2025-11-12 | 2025-11-07 | 4 | 0001493152-25-021614 | View SEC Doc Filr Page |
| 4 | 2025-11-04 | 2025-10-31 | 4 Filing | 0001493152-25-020675 | View SEC Doc Filr Page |
| ARS | 2025-11-03 | 2024-12-31 | ARS | 0001493152-25-020628 | View SEC Doc Filr Page |
| DEFA14A | 2025-11-03 | — | DEFA14A | 0001493152-25-020627 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-03 | 2025-11-03 | DEF 14A | 0001493152-25-020623 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001641172-25-024066 | View SEC Doc Filr Page |
| 8-K | 2025-07-24 | 2025-07-19 | 8-K | 0001641172-25-020843 | View SEC Doc Filr Page |
| 10-Q | 2025-05-20 | 2025-03-31 | 10-Q | 0001641172-25-011731 | View SEC Doc Filr Page |
| NT 10-Q | 2025-05-15 | 2025-03-31 | NT 10-Q | 0001641172-25-010936 | View SEC Doc Filr Page |